UK markets open in 5 hours 55 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.28 +0.33 (+0.42%) GOLD FUTURES
2,312.80 +3.20 (+0.14%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,155.40 +1,077.17 (+2.34%)
Medigen Biotechnology Corp. (3176.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
As of 01:30PM CST. Market open.
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 5.45B |
| Enterprise value | 3.75B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.71 |
| Price/book (mrq) | 3.42 |
| Enterprise value/revenue | 3.24 |
| Enterprise value/EBITDA | -3.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.59 |
| 52-week change 3 | 10.89% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 62.40 |
| 52-week low 3 | 30.30 |
| 50-day moving average 3 | 39.68 |
| 200-day moving average 3 | 40.19 |
Share statistics
| Avg vol (3-month) 3 | 306.23k |
| Avg vol (10-day) 3 | 225.4k |
| Shares outstanding 5 | 139.35M |
| Implied shares outstanding 6 | 139.35M |
| Float 8 | 130.21M |
| % held by insiders 1 | 25.22% |
| % held by institutions 1 | 2.80% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -48.48% |
| Operating margin (ttm) | -149.39% |
Management effectiveness
| Return on assets (ttm) | -8.33% |
| Return on equity (ttm) | -25.64% |
Income statement
| Revenue (ttm) | 1.16B |
| Revenue per share (ttm) | 8.31 |
| Quarterly revenue growth (yoy) | 82.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.08B |
| Net income avi to common (ttm) | -561.3M |
| Diluted EPS (ttm) | -4.03 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.59B |
| Total cash per share (mrq) | 32.92 |
| Total debt (mrq) | 2.86B |
| Total debt/equity (mrq) | 57.33% |
| Current ratio (mrq) | 2.05 |
| Book value per share (mrq) | 11.42 |
Cash flow statement
| Operating cash flow (ttm) | -503.52M |
| Levered free cash flow (ttm) | -190.22M |
© 2024 Yahoo. All rights reserved.